Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quality improvement case study: warfarin sodium interactions.

Andrew D Weinberg1, Julie S Altman, Jean K Pals

  • 1University of South Carolina School of Medicine, Columbia, SC, USA. andrew.weinberg@med.va.gov

Journal of the American Medical Directors Association
|June 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants.

Cell·2023
Same author

OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines.

Frontiers in immunology·2022
Same author

PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors.

The Journal of clinical investigation·2022
Same author

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.

Nature communications·2021
Same author

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.

Genome medicine·2020
Same author

OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function.

Journal of immunology (Baltimore, Md. : 1950)·2019
Same journal

Pilot Implementation of the Shed-MEDS Deprescribing Intervention for Persons With Dementia in Assisted Living Facilities.

Journal of the American Medical Directors Association·2026
Same journal

Disease-Related Factors Contributing to the Increase in the Frequency of Care Provided by Working Family Caregivers During the COVID-19 Pandemic: A Cross-Sectional Study.

Journal of the American Medical Directors Association·2026
Same journal

Frailty Trajectories in Men Aged 71 Years or Older Living in Western Australia: Results From the Health in Men Study.

Journal of the American Medical Directors Association·2026
Same journal

Resident- and Facility-Level Correlates of Resident-Reported Quality of Life in Assisted Living Facilities in Minnesota.

Journal of the American Medical Directors Association·2026
Same journal

The Embedded Model for Bridging Essential Delivery of Care in Assisted Living Facilities-EMBED-ALF.

Journal of the American Medical Directors Association·2026
Same journal

Opportunities for Improving End-of-Life Care for Veterans Receiving Hospice in Community Nursing Homes.

Journal of the American Medical Directors Association·2026
See all related articles

Antibiotic use in warfarin patients can cause dangerous drug interactions. This case highlights the critical need for careful medication review in nursing facilities to prevent adverse events.

Area of Science:

  • Pharmacology
  • Geriatric Medicine
  • Internal Medicine

Background:

  • Warfarin is a common anticoagulant medication used in elderly patients.
  • Nursing facility residents often have multiple comorbidities and polypharmacy.
  • Antibiotics are frequently prescribed for infections in this population.

Observation:

  • A case study involving a warfarin-treated nursing facility resident experiencing a dangerous drug interaction.
  • The interaction occurred due to the concurrent use of an antibiotic medication.
  • Details of the incident were anonymized to protect patient confidentiality.

Findings:

  • Certain antibiotics can significantly alter the metabolism and efficacy of warfarin.
  • This alteration can lead to supratherapeutic or subtherapeutic anticoagulation levels.

Related Experiment Videos

  • Potential for serious bleeding or thrombotic events exists.

    • Implications:

    • Highlights the critical need for vigilant medication management in nursing facilities.
    • Emphasizes the importance of healthcare providers being aware of potential antibiotic-warfarin interactions.
    • Suggests enhanced protocols for medication reconciliation and monitoring are necessary for vulnerable patient populations.